Scholarlink

Purpose <p>To report the clinical presentation, systemic associations, microbiologic spectrum, management strategies, and treatment outcomes of patients with culture-proven endogenous endophthalmitis.</p> Methods <p>A retrospective review of medical records was conducted of patients with culture-proven endogenous endophthalmitis between 2013 and 2024. Data collected included demographics, systemic and ocular findings, culture results, imaging studies, management strategies, and treatment outcomes.</p> Results <p>A total of 50 eyes from 41 patients were identified. Of these, 30/41 (73%) presented in an outpatient setting. The most common presenting symptom was blurred vision in 36/41 (88%) with only 16/41 (39%) presenting with systemic symptoms. Vitreous cultures disclosed fungal organisms in 19/41 (46%) of cases and bacterial in the remainder. Blood cultures were positive in 23/41 (56%). A systemic source of infection was identified in 23/41 (56%), most often associated with indwelling medical devices in 7/23 (30%). Intravenous drug use was present in 7/41 (17%). All patients received intravitreal antimicrobials and 25/50 (50%) underwent vitrectomy. Death associated with systemic infection occurred in only 3/41 (7%) of patients. Evisceration was performed in 2/50 (4%) eyes. Visual acuity at last follow up was ≥ 20/400 in 26/50 (52%) of eyes.</p> Conclusions <p>Endogenous endophthalmitis was associated with a fungal source in 46% of cases and was not associated with systemic symptoms in 61% of cases. In the current study, indwelling medical devices remain an important source of infection. Despite prompt treatment, visual outcomes were generally poor.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Culture-proven endogenous endophthalmitis: ocular and systemic clinical features and outcomes

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年5月25日

查看全文
  • Charles Zhang,
  • Mariam Tadross,
  • Sujin Kang,
  • Nicolas A. Yannuzzi,
  • Thomas A. Albini,
  • Harry W. Flynn

摘要

Purpose

To report the clinical presentation, systemic associations, microbiologic spectrum, management strategies, and treatment outcomes of patients with culture-proven endogenous endophthalmitis.

Methods

A retrospective review of medical records was conducted of patients with culture-proven endogenous endophthalmitis between 2013 and 2024. Data collected included demographics, systemic and ocular findings, culture results, imaging studies, management strategies, and treatment outcomes.

Results

A total of 50 eyes from 41 patients were identified. Of these, 30/41 (73%) presented in an outpatient setting. The most common presenting symptom was blurred vision in 36/41 (88%) with only 16/41 (39%) presenting with systemic symptoms. Vitreous cultures disclosed fungal organisms in 19/41 (46%) of cases and bacterial in the remainder. Blood cultures were positive in 23/41 (56%). A systemic source of infection was identified in 23/41 (56%), most often associated with indwelling medical devices in 7/23 (30%). Intravenous drug use was present in 7/41 (17%). All patients received intravitreal antimicrobials and 25/50 (50%) underwent vitrectomy. Death associated with systemic infection occurred in only 3/41 (7%) of patients. Evisceration was performed in 2/50 (4%) eyes. Visual acuity at last follow up was ≥ 20/400 in 26/50 (52%) of eyes.

Conclusions

Endogenous endophthalmitis was associated with a fungal source in 46% of cases and was not associated with systemic symptoms in 61% of cases. In the current study, indwelling medical devices remain an important source of infection. Despite prompt treatment, visual outcomes were generally poor.